A 10-month-old male infant was referred due to refractory metabolic acidosis. He had presented with respiratory distress after 2 days of vomiting. Past and family histories were unremarkable except for parental consanguinity. There was no known exposure to drugs or toxins. Growth and development were normal. Upon arrival, he had severe Kussmaul breathing despite being sedated and intubated. Vital signs were: temperature 36.3 C, heart rate 167/min, respiratory rate 66/min, blood pressure 95/55 mmHg, oxygen saturation 98%. He was comatose (Infant Glasgow Coma Scale score: 6) and moderately dehydrated with otherwise unremarkable physical examination. He had severe high anion gap metabolic acidosis (blood pH 6.90, bicarbonate 2.8 mmol/L, anion gap 29.2 mmol/L) with leucocytosis (41.5 × 10 3 /μL), hyperuricaemia (16.5 mg/dL), hyperammonaemia (163 μmol/L), normal glucose, lactate and significant ketonuria (3+ with dipstick).
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He was admitted to the paediatric intensive care unit with a presumptive diagnosis of organic acidaemia. Dried blood spots, plasma and urine samples were obtained and stored for future testing. He was kept nil orally and given glucose, insulin and lipid infusions to promote anabolism. Levocarnitine, biotin, hydroxycobalamin and intravenous bicarbonate were started. As acidosis was refractory, continuous venovenous hemodiafiltration (CVVH) was performed for 24 h. Blood gases, breathing pattern, ammonia normalised, ketonuria disappeared and he was extubated within 12 h of CVVH. Low-protein formula feeding was initiated. Electroencephalogram and brain magnetic resonance imaging were normal. Consciousness improved on day 5 and the patient recovered without any apparent deficits. Ketonuria did not recur during the hospital stay. He was discharged in good neurologic condition.
Results of metabolic analyses on the initial critical samples were available on day 6. Unexpectedly; carnitine, acylcarnitines, amino acids and urinary acylglycines were normal. Urine organic acids were also normal except for markedly elevated ketone bodies β-hydroxybutyric acid (13 270 mmol/mol creatinine; normal range: 0-11) and acetoacetate. Organic acidaemias were thus ruled out; protein restriction, levocarnitine, biotin and hydroxycobalamin were discontinued. Disorders of ketone utilisation were suspected ( Table 1) . As succinyl-CoA:3-ketoacid transferase (SCOT) deficiency was the most likely culprit, sequencing of OXCT1 gene was ordered, which encodes SCOT enzyme. A previously unreported, homozygous missense variant c.424G>C (p.Ala142Pro) was detected in OXCT1 (RefSeq NM_000436.3), which is not included in gnomAD or ClinVar databases. In silico variant analysis tools Mutation Taster (NeuroCure Cluster of Excellence, Berlin, Germany), PROVEAN (J. Craig Venter Institute, CA, USA), PolyPhen-2 (Harvard University, Cambridge, MA, USA) and SIFT (Pauline Ng, Singapore) predict that this variant is likely pathogenic. Therefore, c.424G>C (p.Ala142Pro) variant in OXCT1 gene is likely to be a novel pathogenic variant (mutation) associated with SCOT deficiency, virtually confirming the diagnosis in the present case. This sequence data has been submitted to the Clin-Var database under the accession number SCV000902433.
Discussion
Metabolic acidosis is a challenge at the paediatric emergency department. Anion gap helps differentiate between conditions with accumulation of unmeasured anions (high anion gap) or loss of bicarbonate (normal anion gap). High anion gap metabolic acidosis with ketonuria is the presenting feature of many inborn errors of metabolism (IEM), including mitochondrial diseases, disorders of ketone utilisation and most commonly, organic acidaemias. 1 As IEMs are rare but crucial to diagnose, paediatricians must keep a high index of suspicion, especially in critically ill children at any age with no obvious aetiology. Absence of a history of drug intoxication and the presence of parental
Key Points
1 As delays in treatment may result in death or irreversible sequelae, paediatricians should keep a high index of suspicion for inborn errors of metabolism in acutely ill children of any age, and consider inherited disorders of ketone utilisation in the differential diagnosis of salicylate intoxication and high anion gap metabolic acidosis ('Think Metabolic!'). 2 Collection and appropriate storage of pre-treatment critical samples during the acute attack is important for accurate diagnosis of many inborn errors of metabolism. 3 Treatment of succinyl-CoA:3-ketoacid transferase deficiency mainly consists of preventing catabolism during periods of stress by providing frequent feedings and high calories, but may require intensive care monitoring and extracorporeal detoxification in refractory cases.
consanguinity, which increases the risk of autosomal recessive conditions, raised the possibility of an IEM in this patient.
In an acutely ill patient with possible metabolic disease, it is crucial to collect and store critical plasma and urine samples and dried blood spots for future testing. 1 Treatment might result in clearance of the accumulated metabolites, rendering a posttreatment sample non-diagnostic. In the present case, since ketonuria did not persist after the initial attack, samples collected after CVVH could not have been diagnostic, underlining the role of the paediatrician in obtaining critical samples.
Empirical emergency treatment was directed towards organic acidaemias, as acutely ill non-diabetic children with significant ketoacidosis and no history of drug intoxication should be accepted as organic acidaemia unless proven otherwise. 2, 3 After organic acidaemias were ruled out by metabolic investigations and mitochondrial diseases were considered unlikely due to normal brain magnetic resonance imaging and rapidly improving clinical status, differential diagnosis shifted to disorders of ketone utilisation. There are three known inherited disorders of ketone utilisation (Table 1) : Mitochondrial acetoacetyl-CoA thiolase (T2) deficiency is the most common type, and shows additional abnormalities in acylcarnitine and organic acid profiles other than ketonuria; whereas SCOT deficiency and monocarboxylate transporter 1 deficiency do not, making them not currently amenable to newborn screening. 4 Parental consanguinity with no metabolic abnormalities other than ketosis made SCOT deficiency the most likely candidate, prompting sequencing of OXCT1 gene and the subsequent diagnosis of SCOT deficiency in this patient.
SCOT deficiency is a rare IEM with fewer than 40 patients reported. 4 Although permanent ketosis is considered a hallmark of the severe form of SCOT deficiency, the case presented here challenges this view with disappearance of ketonuria after the acute episode. Previous reports of OXCT1 variants similarly not associated with permanent ketosis do exist. 5, 6 The novel mutation reported in this paper is possibly one such variant. Although treatment consists only of avoidance of fasting and preventing catabolism during periods of acute stress, refractory decompensations may require parenteral calories or even hemodialysis, as in the present case. 7 Initiation of CVVH in a timely manner was central to this patient's management since it resulted in rapid resolution of acidosis, preventing irreversible neurologic sequela.
It is worthy to note that extremely high ketone levels can cause false positive results in tests for salicylates. As salicylate intoxication is much more common and may also cause critical illness with high anion gap metabolic acidosis, patients with severe ketoacidosis due to IEMs can be easily misdiagnosed as salicylate intoxication, especially during the first acute attack. 8 Paediatricians are advised to consider inherited disorders of ketone metabolism in children with salicylate intoxication or unexplained metabolic acidosis with high anion gap.
As delays in treatment may result in death or irreversible sequelae, paediatricians should keep a high index of suspicion for IEMs in acutely ill children of any age and consider inherited disorders of ketone utilisation in the differential diagnosis of salicylate intoxication and high anion gap metabolic acidosis. Collection and appropriate storage of pre-treatment critical samples during the acute attack is important for accurate diagnosis of SCOT deficiency, as in many other IEMs. 
